|
|
5S Langouët Key Opinion Leader In [S Langouët is considered a key opinion leader in any keyword where the rank of 5 is achieved, the leading number before the keyword shows the author's rank as compared to all other authors]- 8Quinoxalines | 10Cytochrome P-450 CYP1A2 | 33Mutagens | 84Hepatocytes
Keywords (32) [keywords assigned to S Langouët articles by PubMed, the leading number and the color conveys importance]- 4Rats | 4Hepatocytes | 4Animals | 4Humans | 3Quinoxalines | 3Cytochrome P-450 CYP1A2 | 3Cells, Cultured | 3Mutagens | 2Tumor Cells, Cultured | 2Theophylline | 2Metabolic Detoxication, Drug | 2DNA Adducts | 2Microsomes, Liver | 2Biotransformation | 2Enzyme Inhibitors | 1Benzopyrenes | 1Species Specificity | 1Vincristine | 1Multidrug Resistance-Associated Proteins | 1RNA, Messenger | 1Recombinant Proteins | 1Substrate Specificity | 1Cisplatin | 1Chromatography, High Pressure Liquid | 1Carcinogens | 1Molecular Structure | 1Antineoplastic Agents | 1P-Glycoprotein | 1Methylcholanthrene | 1Rats, Wistar | 1P-Glycoproteins | 1Drug Resistance, Multiple
Other [context-specific ads]S Langouët Unique Vocabulary (96) [single words, word pairs and phrases obtained by analysis of abstracts and titles, the leading number and the color conveys importance; S Langouët might be a good expert witness on these terms]- 12cells | 8human | 75-f | 7quinoxaline | 7liver | 6resistance | 6p450 | 6rat | 58-dimethylimidazo | 52-amino-3 | 5multidrug | 5metabolism | 51a2 | 4differences | 4f258 | 4transporters | 4pathway | 43mc | 4meiqx | 4pah | 3hepatocytes | 3major | 3activity | 3expression | 3efflux | 2acid | 2p-glycoprotein | 2mutagen | 2risk | 2considered | 2affect | 2mrp2
- 5multidrug resistance | 52-amino-3 8-dimethylimidazo | 5quinoxaline human | 58-dimethylimidazo 5-f | 55-f quinoxaline | 5p450 1a2 | 5rat liver | 4resistance transporters | 4liver cells | 3human hepatocytes | 33mc cells | 3human rat | 3expression multidrug | 3f258 3mc | 2detoxification pathway | 2considered assessing | 2assessing human | 2affect biological | 2unaltered expression | 2polycyclic aromatic | 2transporters polycyclic | 21a2 quinoxaline | 2n-oxidation 2-amino-3 | 2health risk | 2must considered | 25-f quinoxaline-8-carboxylic | 2liver microsomes | 2catalyzed cytochrome | 2human health | 2cytochrome p450 | 2regioselective differences | 2major detoxification
- 55-f quinoxaline human | 52-amino-3 8-dimethylimidazo 5-f | 58-dimethylimidazo 5-f quinoxaline | 4multidrug resistance transporters | 3quinoxaline human hepatocytes | 3expression multidrug resistance | 3f258 3mc cells | 2cytochromes p450 1a2 | 2unaltered expression multidrug | 2rat liver microsomes | 2aromatic hydrocarbon-resistant rat | 2major detoxification pathway | 2n-oxidation 2-amino-3 8-dimethylimidazo | 2hydrocarbon-resistant rat liver | 2quinoxaline human rat | 2hepatocytes 2-amino-3-methylimidazo 5-f | 2affect biological activity | 2rat liver cells | 2p450 1a2 quinoxaline | 2regioselective differences n-oxidation | 2must considered assessing | 2polycyclic aromatic hydrocarbon-resistant | 2quinoxaline-8-carboxylic acid major | 2metabolism 2-amino-3 8-dimethylimidazo | 2detoxification pathway catalyzed | 2pathway catalyzed cytochrome | 2transporters polycyclic aromatic | 2considered assessing human | 2differences n-oxidation 2-amino-3 | 2acid major detoxification | 2resistance transporters polycyclic | 2human hepatocytes 2-amino-3-methylimidazo
Science Trivia (2) [Interactive math & science trivia questions]
|
|